Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
A. Kaltenböck, K. Dubischar-Kastner, E. Schuller, Mahima Datla, C.S. Klade, T.S.A. KishoreVolume:
28
Year:
2010
Language:
english
DOI:
10.1016/j.vaccine.2009.10.024
File:
PDF, 144 KB
english, 2010